Fluorescence and chemiluminescence behavior of distyrylbenzene bearing two arms of dipicolylaminomethyl groups: Interactions with zinc ion and ATP

A Fluorescence Enhancement Sensor Based on Silver Nanoclusters Protected by Rich-G-DNA for ATP Detection

In this study, a turn-on fluorescence sensor for the detection of adenosine 5'-triphosphate (ATP) was developed and tested using ATP-DNA2-Ag NCs. The results showed that the fluorescence of ATP-DNA2-Ag NCs was significantly enhanced with the addition of ATP. The fluorescence enhancement was a result of the specific binding activity of the ATP aptamer and ATP, which caused G-rich sequences to approach the dark DNA-Ag NCs, owing to the alteration in ATP aptamer conformation. The proposed sensor demonstrated a good linear range of 18-42 mM and a limit of detection (LOD) of 2.8 μM. The sensor's features include sensitivity, selectivity, and simple operation. In addition, the proposed sensor successfully measured ATP in 100-fold diluted fetal bovine serum.

Turn-on fluorescent nanoprobe for ATP detection based on DNA-templated silver nanoclusters

A turn-on fluorescence nanoprobe was constructed for the determination of adenosine 5'-triphosphate (ATP) based on DNA-templated silver nanoclusters (DNA-AgNCs). The significant enhancement fluorescence intensity of DNA-AgNCs in the presence of ATP is due to the high special binding affinity between ATP and the aptamer, resulting in the environment of DNA-AgNCs with darkish fluorescence lying at one terminus of DNA slightly altering owing to the change of ATP aptamer conformation. A good linear range runs from 9 to 24 mM with a satisfactory detection limit of 3 μM. Furthermore, the proposed nanoprobe exhibited good performance for ATP detection in diluted fetal bovine serum.

Quantifying the drug response of patient-derived organoid clusters by aggregated morphological indicators with multi-parameters based on optical coherence tomography

Patient-derived organoids (PDOs) serve as excellent tools for personalized drug screening to predict clinical outcomes of cancer treatment. However, current methods for efficient quantification of drug response are limited. Herein, we develop a method for label-free, continuous tracking imaging and quantitative analysis of drug efficacy using PDOs. A self-developed optical coherence tomography (OCT) system was used to monitor the morphological changes of PDOs within 6 days of drug administration. OCT image acquisition was performed every 24 h. An analytical method for organoid segmentation and morphological quantification was developed based on a deep learning network (EGO-Net) to simultaneously analyze multiple morphological organoid parameters under the drug's effect. Adenosine triphosphate (ATP) testing was conducted on the last day of drug treatment. Finally, a corresponding aggregated morphological indicator (AMI) was established using principal component analysis (PCA) based on the correlation analysis between OCT morphological quantification and ATP testing. Determining the AMI of organoids allowed quantitative evaluation of the PDOs responses to gradient concentrations and combinations of drugs. Results showed that there was a strong correlation (correlation coefficient >90%) between the results using the AMI of organoids and those from ATP testing, which is the standard test used for bioactivity measurement. Compared with single-time-point morphological parameters, the introduction of time-dependent morphological parameters can reflect drug efficacy with improved accuracy. Additionally, the AMI of organoids was found to improve the efficiency of 5-fluorouracil(5FU) against tumor cells by allowing the determination of the optimum concentration, and the discrepancies in response among different PDOs using the same drug combinations could also be measured. Collectively, the AMI established by OCT system combined with PCA could quantify the multidimensional morphological changes of organoids under the drug's effect, providing a simple and efficient tool for drug screening in PDOs.

A label-free aptasensor for the detection of ATP based on turn-on fluorescence DNA-templated silver nanoclusters

A label-free aptasensor has been fabricated in order to detect adenosine triphosphate (ATP) using turn-on fluorescence DNA-Ag NCs. The fluorescence of the DNA-Ag NCs could increase remarkably with the addition of ATP mainly because ATP specifically interacts with its aptamer to change the microenvironment of the darkish DNA-Ag NCs located at one terminus or two termini due to the conformational alteration of the aptamer structure. The proposed sensor can detect ATP in a linear range of 6-27 mM with a good detection limit of 5.0 μM. Additionally, the proposed method succeeded in detecting ATP in fetal bovine serum.

Cerium doped magnetite nanoparticles for highly sensitive detection of metronidazole via chemiluminescence assay

Cerium doped magnetite nanoparticle (CDM) was synthesized via a co-precipitation method and used as the co-reactant of luminol-K₃Fe(CN)₆ chemiluminescent system. The physical-chemical features of CDM were studied by XPS, XRD, HRTEM, FESEM, VSM, BET, and FTIR analyses. This simple and highly sensitive nanoprobe enabled the determination of minor concentrations of metronidazole (MNZ). Owing to the quenching efficacy of MNZ in the studied chemiluminescence system, a linear range of 3.47 × 10^-6-9.37 × 10^-5 mol/L was obtained with a limit of detection of 3.91 × 10^-7 mol/L. This biosensor was used for MNZ detection in human serum samples, which was highly efficient. The outcomes of this study give credit to the proposed biosensor to be applied for detection of MNZ in biological samples.

Selective monitoring ATP using a fluorogenic Al(III)-probe complex in aqueous medium

A simple commercially available probe 8-hydroxyjulolidine-9-aldehyde (HJ) has been developed as a turn-on fluorescent probe specifically for Al³⁺ and characterized systemically. The probe HJ for Al³⁺ ion exhibits strong green fluorescence under ultraviolet light. The HJ acted as an OFF-ON-OFF type fluorescent probe for Al³⁺ and ATP in nearly 100% aqueous media. The 1:1 binding stoichiometry between probe and Al³⁺ has been established from Job's plot and HRMS studies. The limit of detection for Al³⁺ ion is found to be 5.75 × 10^-8 M. The large association constant between HJ and Al³⁺ ion is 1.05 × 10⁵ M^-1. Detailed insights of probe-metal interaction mechanisms have been studied by the density functional theory (DFT) as well as the time dependent-DFT (TDDFT) calculations. Moreover, benefiting from the water solubility and biocompatibility of the probe HJ and its HJ-Al³⁺ complex, they have also been successfully applied to detect Al³⁺ and ATP by bioimaging in onion epidermal cells and adult zebrafish respectively.

A label-free fluorescent probe for the detection of adenosine 5'‑triphosphate via inhibiting the aggregation-induced emission enhancement of glutathione modified silver nanoclusters triggered by zinc ion

It is important to establish sensitive and simple analysis methods for adenosine 5'‑triphosphate (ATP). A label-free fluorescent probe for the determination of ATP was constructed based on glutathione modified silver nanoclusters (AgNCs/GSH). AgNCs/GSH showed aggregation-induced emission enhancement (AIEE) property in the organic solvent. The effects of metal ions on the fluorescence of AgNCs/GSH were also studied. Only zinc ion enhanced the fluorescence of AgNCs/GSH obviously. This was because Zn²⁺ coordinated with AgNCs/GSH to cause the aggregation of AgNCs/GSH, which was sufficiently proved by TEM. With the addition of ATP, Zn²⁺ bound with ATP through ZnOP bond and the binding between Zn²⁺ and AgNCs/GSH was inhibited. Hence the fluorescence of AgNCs/GSH was decreased with increasing the ATP concentration. The fluorescence response was linear in the ATP concentration range of 1-110 μM, and the detection limit was 0.8 μM. Then this method was successfully applied for determining ATP in the samples of human urine and rat serum, the recoveries were in the range of 97.6%-103%.